Lee HS, Jang HJ, Ramineni M, Wang DY, et al. A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res 2023;29:548-559.
PMID: 36469573